Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1045435C details potent bronchodilators. We analyze the scalable reduction and heterocycle coupling methods for cost-effective API intermediate manufacturing.
Patent CN109020865A reveals safer Pd-catalyzed reduction. Delivers cost reduction in API manufacturing and high-purity pharmaceutical intermediates for global supply chains.
Patent CN111320587A reveals a greener one-pot route for 1H-1,2,3-triazole. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN105037314A details a novel gastric cancer intermediate synthesis offering simplified processing and substantial supply chain cost reduction advantages.
Patent CN111995606B reveals a novel aqueous nucleophilic substitution for 7-methyl ketone luteolin and quercetin, offering significant cost reduction and scalable manufacturing.
Patent CN103613524A details a novel route for Se-methylselenocysteine offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102046645B details a one-pot synthesis for high-purity spiroketal derivatives. This method ensures supply chain stability and cost reduction in API intermediate manufacturing.
Novel synthesis route for Ondansetron intermediate offers high purity and yield, reducing costs and supply chain risks for pharmaceutical manufacturers globally.
Patent CN115927507A reveals a novel enzymatic route for oligosaccharides. Achieve significant cost reduction in pharmaceutical intermediates manufacturing via ATP regeneration.
Novel stereoselective method for CGRP antagonist intermediate ensures high purity and scalable production for global pharmaceutical supply chains.
Patent CN113584507B reveals a green continuous flow electrochemical method for sulfonylated isoindolinone, offering metal-free production and scalable supply chain solutions.
Novel Lewis acid catalyzed synthesis of hexahydropyrrolo indole intermediates ensures high yield and scalable process for pharmaceutical supply chain optimization and cost efficiency.
Novel ionic liquid palladium catalysis improves yield and selectivity for dexmedetomidine intermediate manufacturing supply chain efficiency.
Patent CN101898990B details Rhodococcus erythropolis AJ270 catalyzed hydrolysis for high-purity chiral azetidine intermediates, offering cost-effective scalable manufacturing solutions.
Discover advanced synthesis routes for beta-alanine derivatives per CN1329595A. Enhance supply chain stability and reduce manufacturing costs for cardiovascular API intermediates.
Novel PAMO enzyme technology enables green, one-step synthesis of esomeprazole with >99% ee, eliminating sulfone byproducts and reducing manufacturing costs for pharmaceutical supply chains.
Patent CN103382213B details a gold-catalyzed route for novel antitumor steroid intermediates, offering high yield and scalable manufacturing for pharmaceutical supply chains.
Advanced synthesis of benzoyl acrylic podophyllotoxin esters via patent CN113185529B offers reduced toxicity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN112481226A discloses solvent-tolerant ADH mutants enabling 99.9% conversion for chiral diaryl alcohols, offering a green alternative to costly chemical synthesis.
Patent CN111995608A details a novel C-O coupling method for luteolin-quercetin dimers. Discover cost-effective manufacturing and high-purity antiviral intermediates.